Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose effects on cardiac systolic and diastolic function in elderly surgical patients
ChiCTR2300076124Phase 4Recruiting
- Sponsor
- Department of Anesthesia, Zhujiang Hospital, Southern Medical University
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine (2 arms), sponsored by Department of Anesthesia, Zhujiang Hospital, Southern Medical University. Primary endpoints: Ejection fraction and Ratio of maximum flow velocity in early diastolic phase to maximum flow velocity in late diastolic phase. Started Feb 2023; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2300076124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076124.